NASDAQ · Biotechnology

Immunitybio Inc (IBRX)

$9.69 -6.65%

Add alert

61 In band Daily RSI (14) · 6 Oct 2026

Moving averages

SMA 200$6.72+44.20%

Company profile

ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose chemotherapy.

SectorHealthcare

IndustryBiotechnology

Market cap$8.38B

P/E ratioNone

EPS$-0.95

Beta0.135

Dividend yield0.00%

52-week high$12.43

52-week low$1.95

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 43 VRTX Vertex Pharmaceuticals Inc RSI 38 CRSP CRISPR Therapeutics AG RSI 46 IOVA Iovance Biotherapeutics Inc RSI 79 MRNA Moderna Inc RSI 71 VKTX Viking Therapeutics Inc RSI 41 SRPT Sarepta Therapeutics Inc RSI 38 EDIT Editas Medicine Inc RSI 51 NVAX Novavax Inc RSI 77 DNA Ginkgo Bioworks Holdings Inc - Class A RSI 82

Free forever

RSI alerts for IBRX

Get an email the moment Immunitybio Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 13 September 2026 at 7:06 AM EDT